September 23, 2021 |
Healthcare communications agency, Cuttsy+Cuttsy, has been awarded ‘We invest in People, Gold’ from Investors in People.
Healthcare communications agency, Cuttsy+Cuttsy, has been awarded ‘We invest in People, Gold’ from Investors in People. Gold accreditation recognises companies that not only have good people practices in place but also involve the whole team in making them come to life.
Paul Devoy, CEO of Investors in People, said: ‘We’d like to congratulate Cuttsy+Cuttsy. Gold accreditation on ‘We invest in people’ is a fantastic effort for any organisation, and places Cuttsy+Cuttsy in fine company with a host of organisations that understand the value of people.’
Commenting on the award, Mathew Cutts, Co-founder and Director at Cuttsy+Cuttsy said, ‘We have always believed in creating a community where people matter; our clients, their patient and healthcare audiences, but also for the team here at Cuttsy+Cuttsy delivering the work. That is why we turned to Investors in People (IIP) to independently verify our outlook and point us in the direction of improvement. We didn’t even imagine we would be awarded Gold at our first attempt.’
‘We’re delighted to have achieved ‘We Invest In People: Gold’ accreditation, first time of applying!’ continues Co-founder and Director, Caroline Benson. ‘The way the team got involved in the process is testament to them and the culture they have helped build.’
Company Details
Latest Content from Cuttsy + Cuttsy
Exploring how empathetic, patient-centred communication can make planned treatment breaks easier to discuss as part of cancer care.
The EU HTA reforms give patients a formal role in assessing new medicines, but meaningful involvement requires more than simply offering them a seat at the table.
As clinical trials accelerate, clear, accessible consent is essential to help participants understand, engage with and remain in a study.
Older trial participants aren’t rejecting digital technology — they’re rejecting poorly designed, inaccessible experiences that make participation harder.
Key takeaways from the Patient Centricity and Engagement conference, exploring how trust, inclusion and meaningful partnership can help turn patient engagement from intention into action.
A single word—manageable—can minimise the real burden of treatment side effects, and it’s time clinical trial communication reflected patients’ lived experience more clearly.
Strong localisation reduces trial friction, supports site teams, improves participant understanding and helps global studies run more smoothly, fairly and efficiently.
Learn what good localisation looks like in clinical trials and why participant-facing materials should feel naturally relevant, culturally appropriate and easy to understand across every market.
Sharing key insights from NEXT Pharma Summit on why trust, clarity and human-centred communication matter more than ever in healthcare.
ASCO 2026 highlighted that low clinical trial recruitment is driven less by patient reluctance and more by gaps in awareness, communication, accessibility and patient education.
